(MMI) announced today that it received FDA investigational device exemption (IDE) to study its microsurgery platform.
MMI won FDA approval to study robotic surgery for Alzheimer’s disease. Elsewhere, SS Innovations’ CEO performed remote bypass ...
The feasibility study, entitled REMIND, Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease, will ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex ...
The MarketWatch News Department was not involved in the creation of this content. JACKSONVILLE, Fla., Oct. 15, 2025 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a robotics company ...
Adnan Siddiqui, MD, PhD, recently used a proprietary robotics system to perform the world’s first microsurgical intracranial brain surgeries.
MMI Completes World's First Robotic Preclinical Study in Neurosurgery with Symani(R) Surgical System
MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced the completion ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback